Literature DB >> 7297090

Quantitative analysis of collagen from normal developing corneas and corneal scars.

C Cintron, B S Hong, C L Kublin.   

Abstract

We measured the relative solubility of collagen in acetic acid after pepsin digestion and tentatively identified the types of collagen present in corneas of rabbits of various ages and in corneal scar tissue, using hydroxyproline assays and polyacrylamide gel electrophoretic analyses. More than 80% of the collagen in normal developing rabbit cornea was soluble after pepsin treatment; no more than 45% of that in two-week-old corneal scars was soluble. The predominant collagens in normal cornea and healing tissue were types I and AB. Type AB increased from 6% of the total collagen in fetal cornea to 11% in cornea from young adults. Collagen from two-week-old corneal wounds contained 16% type AB. Corneal type AB collagen was less soluble and more resistant to degradation by mammalian collagenase than was type I collagen. Unlike the normal cornea, in healing tissue the relative rate of synthesis of type I to type AB collagens did not correspond to their deposition. These results suggest a basic alteration in the molecular structure of the corneal scar, which may be instrumental in preventing the healing tissue from producing a normal, functioning organ.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7297090     DOI: 10.3109/02713688109019966

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  11 in total

1.  Corneal wound healing after photorefractive keratectomy: a 3-year confocal microscopy study.

Authors:  Jay C Erie
Journal:  Trans Am Ophthalmol Soc       Date:  2003

2.  Myofibroblast differentiation modulates keratocyte crystallin protein expression, concentration, and cellular light scattering.

Authors:  James V Jester; Donald Brown; Aglaia Pappa; Vasilis Vasiliou
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-16       Impact factor: 4.799

3.  Structure of corneal scar tissue: an X-ray diffraction study.

Authors:  I M Rawe; K M Meek; D W Leonard; T Takahashi; C Cintron
Journal:  Biophys J       Date:  1994-10       Impact factor: 4.033

4.  Disorganized collagen scaffold interferes with fibroblast mediated deposition of organized extracellular matrix in vitro.

Authors:  Nima Saeidi; Xiaoqing Guo; Audrey E K Hutcheon; Edward A Sander; Shyam Sundar Bale; Suzanna A Melotti; James D Zieske; Vickery Trinkaus-Randall; Jeffrey W Ruberti
Journal:  Biotechnol Bioeng       Date:  2012-05-04       Impact factor: 4.530

5.  Ascorbic acid phosphate ester and wound healing in rabbit corneal alkali burns: epithelial basement membrane and stroma.

Authors:  S Saika; K Uenoyama; K Hiroi; H Tanioka; K Takase; M Hikita
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-04       Impact factor: 3.117

6.  Morphologic characterization of organized extracellular matrix deposition by ascorbic acid-stimulated human corneal fibroblasts.

Authors:  Xiaoqing Guo; Audrey E K Hutcheon; Suzanna A Melotti; James D Zieske; Vickery Trinkaus-Randall; Jeffrey W Ruberti
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

Review 7.  Prelude to corneal tissue engineering - gaining control of collagen organization.

Authors:  Jeffrey W Ruberti; James D Zieske
Journal:  Prog Retin Eye Res       Date:  2008-08-19       Impact factor: 21.198

8.  Collagen type I and type V are present in the same fibril in the avian corneal stroma.

Authors:  D E Birk; J M Fitch; J P Babiarz; T F Linsenmayer
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

9.  Accelerating repaired basement membrane after bevacizumab treatment on alkali-burned mouse cornea.

Authors:  Koon-Ja Lee; Ji-Young Lee; Sung Ho Lee; Tae Hoon Choi
Journal:  BMB Rep       Date:  2013-04       Impact factor: 4.778

10.  Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali Burn.

Authors:  Kislay Roy; Bhasker Sriramoju; Rupinder K Kanwar; Jagat R Kanwar
Journal:  Front Pharmacol       Date:  2016-07-28       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.